Ann Surg Treat Res.  2019 Jun;96(6):283-289. 10.4174/astr.2019.96.6.283.

Long-term effect of bariatric surgery versus conventional therapy in obese Korean patients: a multicenter retrospective cohort study

Affiliations
  • 1Department of Surgery, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Korea.
  • 2Department of Surgery, Inha University School of Medicine, Incheon, Korea.
  • 3National Evidence-based Healthcare Collaborating Agency, Seoul, Korea.
  • 4Department of Surgery, Soonchunhyang University Seoul Hospital, Seoul, Korea. yjgs1997@gmail.com
  • 5Department of Surgery, Chung-Ang University College of Medicine, Seoul, Korea.
  • 6Department of Surgery, Gachon University College of Medicine, Incheon, Korea.
  • 7Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea.
  • 8Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • 9Department of Surgery, CHA Gangnam Medical Center, CHA University School of Medicine, Seoul, Korea.
  • 10Department of Family Medicine, Ewha Women's University School of Medicine, Seoul, Korea.
  • 11Department of Family Medicine, Inha University School of Medicine, Incheon, Korea.
  • 12College of Pharmacy, Kyungpook National University, Daegu, Korea.

Abstract

PURPOSE
Long-term results following bariatric surgery compared to conventional treatments has never been reported in morbidly obese Korean patients. This study aimed to evaluate the long-term efficacy of bariatric surgery in morbidly obese Korean patients compared to conventional medical treatments.
METHODS
In this multicenter retrospective cohort study, we reviewed 137 obese subjects between January 2008 and February 2011 with a body mass index (BMI) > 30 kg/m2 who had more than 5 years of follow-up clinical data after bariatric surgery (surgery group, n = 49) or conventional treatment (conventional treatment group, n = 88). Anthropometric data and the status of comorbidities were compared between the 2 groups.
RESULTS
The median follow-up period was 72.1 months (range 19.3-109.7 months). At the last follow-up, the surgery group showed a greater amount of total weight loss than the conventional treatment group (24.9% vs. 2.8%, P < 0.001). The prevalence of diabetes and hypertension significantly decreased in the surgery group, while the conventional treatment group showed a marked increase in these comorbidities. In the surgery group, Roux-en-Y gastric bypass and sleeve gastrectomy achieved comparable long-term weight loss (26.5% vs. 22.4%, respectively; P = 0.087).
CONCLUSION
In the long-term, bariatric surgery achieved and maintained significantly greater weight reduction, as well as a decrease in obesity-related comorbidities, than did conventional medical therapy in morbidly obese Korean patients.

Keyword

Morbid obesity; Bariatric surgery; Gastric bypass; Gastrectomy

MeSH Terms

Bariatric Surgery*
Body Mass Index
Cohort Studies*
Comorbidity
Follow-Up Studies
Gastrectomy
Gastric Bypass
Humans
Hypertension
Obesity, Morbid
Prevalence
Retrospective Studies*
Weight Loss

Figure

  • Fig. 1 Weight and body mass index changes during the follow-up period in both groups (M, months). Body weight (kg) (A), body mass index (BMI, kg/m2) (B), weight changes (kg) (C), and percent of total weight loss (%TWL) (D).

  • Fig. 2 Anthropometric chronological changes following Roux-en-Y gastric bypass (RYGB) versus sleeve gastrectomy (SG). Body mass index (BMI, kg/m2) (A) and percent of total weight loss (%TWL) (B). M, month.


Cited by  1 articles

Bariatric surgery versus medical therapy in Korean obese patients: prospective multicenter nonrandomized controlled trial (KOBESS trial)
Do Joong Park, Sena An, Young Suk Park, Joo-Ho Lee, Hyuk-Joon Lee, Tae Kyung Ha, Yong-Jin Kim, Seung-Wan Ryu, Sang-Moon Han, Moon-Won Yoo, Sungsoo Park, Sang-Uk Han, Jae-Heon Kang, Jin-Won Kwon, Yoonseok Heo
Ann Surg Treat Res. 2021;101(4):197-205.    doi: 10.4174/astr.2021.101.4.197.


Reference

1. World Health Organization. Obesity and overweight fact sheets [Internet]. Geneva (Switzerland): World Health Organization;c2019. 2018 Oct 10. Available from: http://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
2. National Health Insurance Service. National Health Information Database [Internet]. Wonju (Korea): National Health Insurance Service;c2014. 2018 Oct 10. Available from: https://nhiss.nhis.or.kr/bd/ay/bdaya001iv.do.
3. Shin HY, Kang HT. Recent trends in the prevalence of underweight, overweight, and obesity in Korean adults: The Korean National Health and Nutrition Examination Survey from 1998 to 2014. J Epidemiol. 2017; 27:413–419.
Article
4. Wittgrove AC, Clark GW, Tremblay LJ. Laparoscopic gastric bypass, roux-en-Y: preliminary report of five cases. Obes Surg. 1994; 4:353–357.
Article
5. Scopinaro N. The IFSO and obesity surgery throughout the world. International Federation for the Surgery of Obesity. Obes Surg. 1998; 8:3–8.
6. Pierce J, Galante J, Scherer LA, Chang EJ, Wisner D, Ali M. PL-202: bariatric surgery in the balance: a paradigm shift in general surgery. Surg Obes Relat Dis. 2010; 6:3 Suppl. S10.
Article
7. Heo YS, Park JM, Kim YJ, Kim SM, Park DJ, Lee SK, et al. Bariatric surgery versus conventional therapy in obese Korea patients: a multicenter retrospective cohort study. J Korean Surg Soc. 2012; 83:335–342.
Article
8. Sjostrom L, Larsson B, Backman L, Bengtsson C, Bouchard C, Dahlgren S, et al. Swedish obese subjects (SOS). Recruitment for an intervention study and a selected description of the obese state. Int J Obes Relat Metab Disord. 1992; 16:465–479.
9. Sjostrom L. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013; 273:219–234.
Article
10. Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007; 357:741–752.
Article
11. Sjostrom L, Gummesson A, Sjostrom CD, Narbro K, Peltonen M, Wedel H, et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol. 2009; 10:653–662.
12. Sjostrom L, Peltonen M, Jacobson P, Ahlin S, Andersson-Assarsson J, Anveden A, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014; 311:2297–2304.
Article
13. Sjostrom L, Peltonen M, Jacobson P, Sjostrom CD, Karason K, Wedel H, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012; 307:56–65.
Article
14. Carlsson LM, Peltonen M, Ahlin S, Anveden A, Bouchard C, Carlsson B, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012; 367:695–704.
Article
15. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Nanni G, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2015; 386:964–973.
Article
16. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med. 2017; 376:641–651.
Article
17. Peterli R, Wolnerhanssen BK, Peters T, Vetter D, Kroll D, Borbély Y, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA. 2018; 319:255–265.
18. Salminen P, Helmio M, Ovaska J, Juuti A, Leivonen M, Peromaa-Haavisto P, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial. JAMA. 2018; 319:241–254.
19. Puzziferri N, Roshek TB 3rd, Mayo HG, Gallagher R, Belle SH, Livingston EH. Long-term follow-up after bariatric surgery: a systematic review. JAMA. 2014; 312:934–942.
20. Schwoerer A, Kasten K, Celio A, Pories W, Spaniolas K. The effect of close postoperative follow-up on co-morbidity improvement after bariatric surgery. Surg Obes Relat Dis. 2017; 13:1347–1352.
Article
21. Gould JC, Beverstein G, Reinhardt S, Garren MJ. Impact of routine and long-term follow-up on weight loss after laparoscopic gastric bypass. Surg Obes Relat Dis. 2007; 3:627–630.
Article
22. Compher CW, Hanlon A, Kang Y, Elkin L, Williams NN. Attendance at clinical visits predicts weight loss after gastric bypass surgery. Obes Surg. 2012; 22:927–934.
Article
23. Aarts MA, Sivapalan N, Nikzad SE, Serodio K, Sockalingam S, Conn LG. Optimizing bariatric surgery multidisciplinary follow-up: a focus on patient-centered care. Obes Surg. 2017; 27:730–736.
Article
Full Text Links
  • ASTR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr